Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT

NCT: NCT05340361 · ACTIVE_NOT_RECRUITING

NCT IDNCT05340361
StatusACTIVE_NOT_RECRUITING
Start Date2022-03-23
Completion2026-12-31

Brief Summary

Investigators aimed to evaluate efficacy and safety of expansion capacity of zotarolimus-eluting Stent assessed by optical coherence tomography (OCT) in vivo study.

Frequently Asked Questions

What is Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT?

Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT is a clinical trial registered under NCT05340361. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05340361?

The current status of NCT05340361 (Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT) is: ACTIVE_NOT_RECRUITING.

When did Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT start?

Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT started on 2022-03-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑